ATE192646T1 - Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren - Google Patents
Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwürenInfo
- Publication number
- ATE192646T1 ATE192646T1 AT93903619T AT93903619T ATE192646T1 AT E192646 T1 ATE192646 T1 AT E192646T1 AT 93903619 T AT93903619 T AT 93903619T AT 93903619 T AT93903619 T AT 93903619T AT E192646 T1 ATE192646 T1 AT E192646T1
- Authority
- AT
- Austria
- Prior art keywords
- organic acid
- mixture
- treatment
- production
- medicinal product
- Prior art date
Links
- -1 HYDROXY ORGANIC ACID Chemical class 0.000 title 1
- 208000007117 Oral Ulcer Diseases 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 4
- 208000002399 aphthous stomatitis Diseases 0.000 abstract 3
- 235000014655 lactic acid Nutrition 0.000 abstract 2
- 239000004310 lactic acid Substances 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82324392A | 1992-01-21 | 1992-01-21 | |
| PCT/US1993/000544 WO1993013763A1 (en) | 1992-01-21 | 1993-01-21 | Method of treating small mouth ulcers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE192646T1 true ATE192646T1 (de) | 2000-05-15 |
Family
ID=25238195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93903619T ATE192646T1 (de) | 1992-01-21 | 1993-01-21 | Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US5389679A (de) |
| EP (1) | EP0746313B1 (de) |
| AT (1) | ATE192646T1 (de) |
| CA (1) | CA2128429A1 (de) |
| DE (1) | DE69328635T2 (de) |
| WO (1) | WO1993013763A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2128429A1 (en) * | 1992-01-21 | 1993-07-22 | Howard Alliger | Method of treating small mouth ulcers |
| EP0833568A1 (de) | 1995-06-21 | 1998-04-08 | Oy Extracta Ltd. | Verwendung einer hydroxysäure oder eines sie enthaltenden produktes und ein so hergestelltes produkt |
| JPH11513684A (ja) * | 1995-10-19 | 1999-11-24 | メルク エンド カンパニー インコーポレーテッド | １６−置換−６−アザ−ステロイド５α−レダクターゼ阻害剤 |
| US5872126A (en) * | 1996-09-06 | 1999-02-16 | Merck & Co., Inc. | Methods and compositions for treating preterm labor |
| US7678365B2 (en) * | 2001-04-27 | 2010-03-16 | Kross Robert D | Disinfecting oral rinse compositions and process for using the same |
| EP1682211B1 (de) * | 2003-10-27 | 2009-11-18 | Universität Basel | Transdermales arzneimittelabgabesystem |
| US20070191815A1 (en) * | 2004-09-13 | 2007-08-16 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
| US8252321B2 (en) * | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| US20060115266A1 (en) * | 2004-12-01 | 2006-06-01 | Gil Levi | All-optical protection signaling systems and methods in optical communication networks |
| US20070042026A1 (en) * | 2005-03-17 | 2007-02-22 | Wille John J | Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions |
| US8372040B2 (en) | 2005-05-24 | 2013-02-12 | Chrono Therapeutics, Inc. | Portable drug delivery device including a detachable and replaceable administration or dosing element |
| US8882819B2 (en) | 2011-02-16 | 2014-11-11 | Richard Crowder | Handheld device for treating oral ulcers and sores |
| US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
| US10105487B2 (en) | 2013-01-24 | 2018-10-23 | Chrono Therapeutics Inc. | Optimized bio-synchronous bioactive agent delivery system |
| WO2016123406A1 (en) | 2015-01-28 | 2016-08-04 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
| EP3267875A4 (de) | 2015-03-12 | 2018-12-05 | Chrono Therapeutics Inc. | Eingabe- und unterstützungssystem für heftiges verlangen |
| CN105012689A (zh) * | 2015-06-29 | 2015-11-04 | 孙凤荣 | 一种治疗放化疗所致口腔溃疡的中药制剂 |
| US11426372B2 (en) * | 2015-11-17 | 2022-08-30 | Francisco PAN-MONTOJO | Glycolic acid protects against ischemic insults |
| WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
| CA3101966A1 (en) | 2018-05-29 | 2019-12-05 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| US12397141B2 (en) | 2018-11-16 | 2025-08-26 | Morningside Venture Investments Limited | Thermally regulated transdermal drug delivery system |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3932655A (en) * | 1972-09-14 | 1976-01-13 | International Pharmakon Laboratories, Inc. | Surgical skin scrub |
| US4363815A (en) * | 1975-07-23 | 1982-12-14 | Yu Ruey J | Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions |
| US4117120A (en) * | 1977-02-11 | 1978-09-26 | Elderbaum Gilbert J | Medication for herpes simplex and canker sores |
| US4221794A (en) * | 1979-06-21 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | Method of imparting immunomodulating and antiviral activity |
| US4461724A (en) * | 1981-10-28 | 1984-07-24 | Nippon Zoki Pharmaceutical Co., Ltd. | Peptide compounds, a process for manufacturing them, pharmaceutical compositions containing them, and methods for treating ulcer and thrombus with them |
| GB2134781B (en) * | 1983-02-15 | 1986-02-12 | Diomed Dev Ltd | Composition for the treatment of stasis leg ulcers |
| JPS60248618A (ja) * | 1984-05-24 | 1985-12-09 | Nippon Zoki Pharmaceut Co Ltd | ジペプチドを含有する潰瘍治療剤 |
| US4956184A (en) * | 1988-05-06 | 1990-09-11 | Alcide Corporation | Topical treatment of genital herpes lesions |
| US5227165A (en) * | 1989-11-13 | 1993-07-13 | Nova Pharmaceutical Corporation | Liposphere delivery systems for local anesthetics |
| CA2128429A1 (en) * | 1992-01-21 | 1993-07-22 | Howard Alliger | Method of treating small mouth ulcers |
-
1993
- 1993-01-21 CA CA002128429A patent/CA2128429A1/en not_active Abandoned
- 1993-01-21 WO PCT/US1993/000544 patent/WO1993013763A1/en not_active Ceased
- 1993-01-21 EP EP93903619A patent/EP0746313B1/de not_active Expired - Lifetime
- 1993-01-21 AT AT93903619T patent/ATE192646T1/de not_active IP Right Cessation
- 1993-01-21 DE DE69328635T patent/DE69328635T2/de not_active Expired - Fee Related
- 1993-08-23 US US08/110,336 patent/US5389679A/en not_active Expired - Lifetime
-
1994
- 1994-07-19 US US08/277,349 patent/US5516799A/en not_active Expired - Fee Related
-
1996
- 1996-04-05 US US08/626,134 patent/US5731347A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993013763A1 (en) | 1993-07-22 |
| EP0746313A4 (de) | 1994-10-20 |
| CA2128429A1 (en) | 1993-07-22 |
| DE69328635D1 (de) | 2000-06-15 |
| US5389679A (en) | 1995-02-14 |
| US5731347A (en) | 1998-03-24 |
| DE69328635T2 (de) | 2000-09-07 |
| EP0746313A1 (de) | 1996-12-11 |
| EP0746313B1 (de) | 2000-05-10 |
| US5516799A (en) | 1996-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69328635D1 (de) | Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren | |
| ATE205389T1 (de) | Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma | |
| ATE357214T1 (de) | Verwendung eines unverkapselten anti-krebs- wirkstoffs zur herstellung einer zubereitung zur behandlung von neoplasmen durch inhalation | |
| MX9603520A (es) | Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso. | |
| ATE146677T1 (de) | Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit | |
| ATE231519T1 (de) | Dinukleotide zur verwendung in der behandlung von lungenkrankheiten | |
| ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
| DE69230046D1 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
| ATE336997T1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
| DE69029100D1 (de) | Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris | |
| DE69826023D1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome | |
| DE59508961D1 (de) | Verwendung von weihrauch zur behandlung der alzheimer-krankheit | |
| ATE55695T1 (de) | Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien. | |
| DE69426471D1 (de) | Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie | |
| ATE206914T1 (de) | Verwendung von ursolsäure zur herstellung eines arzneimittels zur unterdrückung von metastasen | |
| DE59902666D1 (de) | Edelfosin zur behandlung von hirntumoren | |
| DE50100833D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| DE69424563D1 (de) | Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis | |
| ATE183390T1 (de) | Verwendung einer kombination von antineoplastonen zur herstellung eines arzneimittels zur behandlung der neurofibromatose | |
| DE69434002D1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
| ATE207353T1 (de) | Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden | |
| ATE173921T1 (de) | Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen | |
| DE69932741D1 (de) | Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen | |
| ATE254919T1 (de) | Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8 | |
| ATE306273T1 (de) | Verwendung von tiludronsäure beim geflügel zur herstellung eines arzneimittels zur prophylaxe und behandlung von osteoporose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |